# SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE)

**Authors:** Jorge L. Martinez-Cajas, Beatriz Alvarado, Ann Jolly, Yanping Gong, Bradley Stoner, Gerald Evans, Santiago Perez-Patrigeon, T. Hugh Guan

PMC · DOI: 10.1371/journal.pone.0303813 · PLOS One · 2025-08-13

## TL;DR

This study tracks healthcare workers in Canada to understand how SARS-CoV-2 spreads and how immune responses and protective measures affect infection risk during different pandemic waves.

## Contribution

The study provides new insights into the bimodal infection risk patterns among healthcare workers during the Omicron wave and the impact of protective measures and vaccination on antibody levels.

## Key findings

- Infection risk among acute care hospital workers increased ninefold during the Omicron wave compared to earlier periods.
- IgG antibody levels rose significantly after the Omicron wave, likely due to increased vaccination and infection rates.
- Use of protective equipment increased during Omicron, but community protective measures decreased.

## Abstract

We established a longitudinal cohort of healthcare workers (HCWs) in an acute care hospital (ACH) and four long-term care homes (LTCHs) in Ontario, Canada, to follow the incidence of SARS-CoV-2 infection, humoral immune response to infection and/or vaccination, and determinants of infection risk. Here, we 1) describe the cohort regarding the distribution of main exposures, outcomes and serologic assays, 2) describe the unadjusted incidence of SARS-CoV-2 infection risk in the overall population, and 3) summarize the analysis and its pertinence.

HCWs were recruited between November 24, 2020, and July 24, 2021. They completed a baseline survey, monthly surveillance for 9–12 months, a post-Omicron-wave survey, and provided blood samples for anti-SARS-CoV-2 antibody measurements. We collected data on host-related (humoral response to vaccines and SARS-CoV-2 infection) and environmental factors (social contact history and occupational, household and community conditions). Descriptive analysis by setting, comparison of distributions, and unadjusted survival analysis were performed.

In total, 143 HCWs from the ACH and 57 from LTCHs had complete data, and 72% were followed until September 2022. Nearly 60% of the sample consisted of nurses, nurse assistants and personal support workers. Survival analysis showed that the risk of infection was bimodal, with low risk throughout the study period until the first Omicron wave. ACH HCWs had a higher risk of infection during the Omicron waves than during the preceding waves (Odds Ratio = 7.64; CI95%: 4.24–13.7), while LTCH HCWs at high-risk facilities experienced a similar risk of infection before and during the Omicron waves (OR = 1.76; CI95%: 0.63–4.9). During the Omicron waves, the use of protective equipment by HCWs working with institutional COVID-19 cases increased, but the use of community protective measures diminished. Household infections reported by participating HCWs also increased during the Omicron waves compared to previous waves. Immunoglobulin G (IgG) antibody levels increased over two time periods, (Pre vs Post- Omicron) likely due to the immune response to high levels of both vaccination and SARS-CoV-2 infections.

We observed a low incidence of COVID-19 until the onset of the Omicron waves, which highlights the drastic impact of this Variants of Concern (VOC) on transmission and the importance of infectious agent characteristics. Our analysis indicated a ninefold increased risk of infection compared to that in earlier pandemic periods. Further analysis will allow the estimation of 1) the risk factors for SARS-CoV-2 infection at the community, household and healthcare facility levels, 2) the relationship between humoral responses and SARS-CoV-2 infection/vaccination, and 3) the role of social contact in work, household and community settings in the risk of infection.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096), COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** N (nucleocapsid phosphoprotein) [NCBI Gene 43740575], ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}
- **Diseases:** Infection (MESH:D007239), respiratory failure (MESH:D012131), COVID-19 (MESH:D000086382), systemic disease (MESH:D034721), fatigue (MESH:D005221), ACH (MESH:D000208), Coronavirus disease (MESH:D018352)
- **Chemicals:** N95 (-)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814], Betacoronavirus (genus) [taxon 694002]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12349196/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12349196/full.md

## References

103 references — full list in the complete paper: https://tomesphere.com/paper/PMC12349196/full.md

---
Source: https://tomesphere.com/paper/PMC12349196